Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy-Reference-Cited by-同舟云学术

Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy

Published:2008-08 Issue:2 Volume:156 Page:241-247
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Bangalore Sripal,Messerli Franz H.,Cohen Jerome D.,Bacher Peter H.,Sleight Peter,Mancia Giuseppe,Kowey Peter,Zhou Qian,Champion Annette,Pepine Carl J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial;Dargie;Lancet,2001

2. Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?;Chen;Arch Intern Med,2000

3. Beta blockade during and after myocardial infarction: an overview of the randomized trials;Yusuf;Prog Cardiovasc Dis,1985

4. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review;Messerli;JAMA,1998

5. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance;Kramer;Am Heart J,2006

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An optimal medical therapy for efficient cardiovascular protection in subjects with coronary artery diseases in Japan: Comparisons and analyses by quasi-randomized controlled trials with propensity score matching and inverse probability treatment weighting methods for a Japanese cohort;Vascular Failure;2020-12-21

2. Stable coronary artery disease;Journal of Hypertension;2019-06

3. Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?;American Journal of Cardiovascular Drugs;2019-03-04

4. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization;Journal of Cardiovascular Medicine;2018-07

5. Pharmacological Strategies for Manipulating Plant Ca2+ Signalling;International Journal of Molecular Sciences;2018-05-18